Why the study?
This review was conducted to examine the interrelationship between oxidative stress, inflammation, and low albumin levels, which are hallmarks of COVID-19.
This review highlights the potential of stable nitroxides as diagnostic tools for monitoring oxidative stress and hypoalbuminemia in COVID-19 patients.
Oxidative stress marks severe cardiovascular pathology; leaves open targeted antioxidant strategies pending trials.
Oxidative stress is a major source of ROS-mediated damage to macromolecules, tissues, and the whole body. It is an important marker in the severe picture of pathological conditions. The discovery of free radicals in biological systems gives a "start" to studying various pathological processes related to the development and progression of many diseases. From this moment on, the enrichment of knowledge about the participation of free radicals and free-radical processes in the pathogenesis of cardiovascular, neurodegenerative, and endocrine diseases, inflammatory conditions, and infections, including COVID-19, is increasing exponentially. Excessive inflammatory responses and abnormal reactive oxygen species (ROS) levels may disrupt mitochondrial dynamics, increasing the risk of cell damage. In addition, low serum albumin levels and changes in the normal physiological balance between reduced and oxidized albumin can be a serious prerequisite for impaired antioxidant capacity of the body, worsening the condition in patients. This review presents the interrelationship between oxidative stress, inflammation, and low albumin levels, which are hallmarks of COVID-19.
No takes yet. Share an insight, caveat, or question.
Georgieva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: